University Of Chicago
Clinical trials sponsored by University Of Chicago, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can your reaction to a drink predict future alcohol problems? Results expected Sep 2026 (estimated)
- Ice vs. High-Tech cool: which eases hand surgery pain best? Results expected Sep 2026 (estimated)
- New hope for young leukemia patients: targeted drug added to chemo Results expected Sep 2026 (estimated)
- Frequent anesthesia may increase risk of waking during surgery Results expected Sep 2026 (estimated)
- Nerve block may ease pain after broken knee surgery Results expected Sep 2026 (estimated)
-
Vitamin B3 may shield retinal nerves in glaucoma
Disease control Not yet recruitingThis trial tests whether high-dose nicotinamide, a form of vitamin B3, can slow the loss of retinal nerve cells in adults with mild to moderate open-angle glaucoma. Participants already on standard glaucoma treatment will be randomly assigned to also take nicotinamide tablets or …
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a home exercise program match formal physical therapy after leg fracture surgery?
Disease control Not yet recruitingThis trial asks whether formal outpatient physical therapy leads to better recovery than a self-guided home exercise program for people who had surgery for a broken thigh or shin bone. Participants will be randomly assigned to one of the two programs and followed for a year with …
Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Weight-Loss drug may rescue lung cancer treatment from metabolic side effects
Disease control Not yet recruitingThis trial tests whether tirzepatide, a medication used for weight management, can reduce the rapid weight gain and metabolic changes caused by lorlatinib, a targeted therapy for ALK-positive non-small cell lung cancer. Adults already taking lorlatinib will receive weekly tirzepa…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a smartphone coach tame high blood pressure?
Disease control Not yet recruitingThis pilot trial is testing a smartphone app that acts like a personal coach to help adults with uncontrolled high blood pressure improve their self-care. The app provides education and interactive coaching to encourage medication adherence and healthy habits. The study will enro…
Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Plant-Based pill help HIV patients quit smoking and drinking?
Disease control Not yet recruitingThis study in Nairobi, Kenya, will test whether a drug called cytisine, combined with counseling, can help 300 people with HIV quit smoking and reduce heavy drinking. Participants will receive either cytisine or a placebo, plus either intensive counseling or standard advice. The …
Phase 3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Weight-Loss drug wegovy tested as Hair-Pulling treatment
Disease control Not yet recruitingThis study tests whether a weekly injection of semaglutide (Wegovy), a drug used for weight loss and diabetes, can help people with trichotillomania (hair-pulling disorder). Ten adults aged 18-75 with daily hair pulling will receive the drug for several weeks. Researchers will me…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Pharmacy techs may unlock HIV shot access for hundreds
Disease control Not yet recruitingThis study tests whether pharmacy technicians can help people with HIV get long-acting injectable medication more easily at community clinics in Chicago. About 465 participants will be observed and may complete surveys or interviews. The goal is to improve access to modern HIV tr…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Engineered t cells take on Hard-to-Treat cancers in new trial
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with advanced ovarian cancer or other solid tumors that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells that are genetically modified to better recognize and attack cancer…
Phase 1/2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug duo aims to shrink tough head and neck tumors
Disease control Not yet recruitingThis study tests whether adding fianlimab to the standard cemiplimab plus chemotherapy can better shrink tumors in adults with advanced HPV-positive head and neck cancer. About 90 participants will receive either the two-drug or three-drug combination before radiation. The goal i…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for frail cancer patients: enhertu trial targets Tough-to-Treat stomach and esophageal tumors
Disease control Not yet recruitingThis study tests the drug Enhertu in 43 people with newly diagnosed HER2-positive stomach, esophageal, or gastroesophageal junction cancer that has spread. Participants have a lower physical ability (ECOG 2) and will receive Enhertu by IV every 3 weeks. The main goal is to see ho…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can step counts predict treatment success in prostate cancer?
Disease control Not yet recruitingThis study looks at whether daily step counts can help monitor how well vulnerable patients with metastatic hormone-sensitive prostate cancer are doing on a combination of darolutamide and standard hormone therapy. About 80 adults who are frail or have other health issues will we…
Phase 4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a common antipsychotic curb Hair-Pulling and Skin-Picking?
Disease control Not yet recruitingThis study tests whether aripiprazole (Abilify) can reduce urges and behaviors in adults with trichotillomania (hair-pulling) or skin-picking disorder. One hundred participants will receive either the drug or a placebo for 6 weeks. Researchers will track symptom changes using sta…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a simple probe placement change improve GERD diagnosis for millions?
Diagnosis Not yet recruitingThis study tests whether placing a pH monitoring probe closer to the stomach (1 cm above the squamocolumnar junction) instead of the standard 6 cm position improves detection of acid reflux in women and people with lower body weight. Participants receive two probes simultaneously…
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Can a Two-Hour class rewire how women feel chronic pelvic pain?
Symptom relief Not yet recruitingResearchers at the University of Chicago are testing whether adding a single-session pain management class called Empowered Relief to standard care helps women with chronic pelvic pain more than standard care alone. The trial enrolls 100 women aged 18 to 70 who have had pelvic pa…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Virtual therapy targets the mind-gut link in IBD
Symptom relief Not yet recruitingThis study tests whether a 10-session virtual group psychotherapy program can help people with inflammatory bowel disease (IBD) who also have anxiety or depression. The therapy is adapted from a standard manual called Mind Over Mood and includes education on the brain-gut connect…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Could adderall help PTSD patients connect better?
Symptom relief Not yet recruitingThis early-stage trial at the University of Chicago tests whether Adderall, a drug used for ADHD, can improve social interactions in people with PTSD. About 40 adults aged 18-65 will receive either Adderall or a placebo and rate their conversations. The goal is to see if this dru…
Phase 1 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could valbenazine ease OCD symptoms? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether valbenazine can safely reduce symptoms in adults with moderate-to-severe obsessive-compulsive disorder (OCD). About 30 participants will receive either the drug or a placebo in a crossover design, meaning everyone gets both over time. The main goal is to …
Phase 2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New study offers Text-Based support to dementia caregivers
Symptom relief Not yet recruitingThis study tests a program called CommunityRx-Dementia, where trained peer mentors help caregivers of people with dementia. Over 12 months, caregivers get a personalized list of community resources, coaching, and supportive text messages. The goal is to reduce loneliness and help…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Could a tiny dose of radiation soothe immunotherapy joint pain?
Symptom relief Not yet recruitingThis study tests whether low-dose radiation can safely ease arthritis pain and swelling that some cancer patients get from immunotherapy. About 20 adults with cancer who developed joint inflammation from their treatment will receive six small radiation doses over 2-3 weeks. The m…
Phase 1 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Blood filtering may tame severe immunotherapy side effects
Knowledge-focused Not yet recruitingThis study looks at whether a procedure called therapeutic plasma exchange—which filters the blood—can help remove immune checkpoint inhibitor drugs from the body in people who develop severe immune-related side effects from cancer treatment. The trial will measure how drug level…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
MSG may boost gut bacteria compound tied to blood sugar problems
Knowledge-focused Not yet recruitingThis trial investigates whether the common flavor enhancer monosodium glutamate (MSG) increases blood levels of imidazole propionate (ImP), a compound produced by gut bacteria from the amino acid histidine. Higher ImP levels have been linked to blood-sugar control issues. Healthy…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Retraining the brain to value food: a new approach for anorexia
Knowledge-focused Not yet recruitingThis study investigates whether a brief training task can change how people with anorexia nervosa value food. Participants view food images and focus on attributes like tastiness or healthiness, then make food choices. The goal is to see if this training makes their choices more …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Apple cider vinegar: surprising new weapon against kidney stones?
Knowledge-focused Not yet recruitingThis study will test whether taking apple cider vinegar every day for a short time changes the chemistry of urine in adults, both those with a history of calcium oxalate kidney stones and healthy volunteers. Researchers will measure levels of citrate, pH, calcium, and calcium oxa…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Waterjet surgery for BPH under the microscope: 3,000-Patient registry launches
Knowledge-focused Not yet recruitingThis registry will follow 3,000 men with benign prostatic hyperplasia (BPH) who undergo Aquablation, a waterjet-based procedure to remove excess prostate tissue. Researchers will collect data from medical records to evaluate how well the procedure improves urinary symptoms and it…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Glucose monitor could spot diabetes risk after pregnancy
Knowledge-focused Not yet recruitingThis study will test whether a continuous glucose monitor (CGM) worn for 14 days after childbirth can predict which women with a history of gestational diabetes are at risk for developing type 2 diabetes. Fifty participants will wear a blinded CGM device and then take a standard …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New study aims to unlock secrets of penetrating brain injuries
Knowledge-focused Not yet recruitingThis study will collect blood samples, brain scans, and medical information from 270 people with penetrating brain injuries. The goal is to create a large research database that scientists can use to better understand these injuries and improve future treatments. Participants mus…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Could chia seeds ease chemo side effects? tiny study aims to find out
Knowledge-focused Not yet recruitingThis study looks at how gut bacteria affect diarrhea and other stomach issues in people with HR+/HER2- breast cancer taking the drug abemaciclib. In the first part, researchers will collect stool samples to track bacteria changes. In the second part, a small group will try eating…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
3D-Printed models could revolutionize transgender surgery education
Knowledge-focused Not yet recruitingThis study will test whether using 3D-printed models of a patient's own anatomy helps transgender individuals better understand peritoneal vaginoplasty surgery. Twenty adults seeking vaginoplasty at the University of Chicago will receive personalized 3D models to aid in education…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Could your gut bacteria predict colon Cancer's return?
Knowledge-focused Not yet recruitingThis study looks at whether certain bacteria in your stool can help predict if colon cancer will come back after surgery. Researchers will collect stool and blood samples from 107 adults before and after their surgery. They want to see if bacteria that break down collagen are lin…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC